Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery

Digestive Diseases and Sciences - United States
doi 10.1007/s10620-016-4302-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Which Patients With Inflammatory Bowel Disease Should Receive Combination Therapy?

Expert Review of Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Prostaglandins in Inflammatory Bowel Disease Therapy

Canadian Journal of Gastroenterology
1993English

Cancer and Reconstructive Surgery in Inflammatory Bowel Disease

Linköping University Medical Dissertations
2019English

Effectiveness of Protease Inhibitor Monotherapy Versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis

PLoS ONE
Multidisciplinary
2011English

Patient Valued Comparative Effectiveness of Corticosteroids Versus Anti-TNF Alpha Therapy for Inflammatory Bowel Disease

2018English

Combination Versus Monotherapy for Nosocomial Pneumonia

European Respiratory Review
PulmonaryRespiratory Medicine
2007English

Author's Answer: Biosimilar Therapy for Inflammatory Bowel Disease

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2014English

Monotherapy Versus Combination Therapy for the Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients

Journal of Antibiotics Research
2018English

Genetics Versus Environment in Inflammatory Bowel Disease: Results of a British Twin Study

BMJ
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy